Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

Recruiting now

Conditions studied: Purpura, Thrombocytopenic

In brief

REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Key facts

Study ID
NCT05914441
Run by
Fundación Española de Hematología y Hemoterapía
People needed
300
Starts
2024-03-22
Expected to finish
2026-12-01
Last updated by the study team
2024-05-29

Who can join

Age: any, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.